Plitidepsin as a successful rescue treatment for prolonged viral SARS CoV 2 replication in a patient with previous anti CD20 monoclonal antibody mediated B cell depletion and chronic lymphocytic leukemia
P. Guisado-Vasco, M. M. Carralón-González, J. Aguareles-Gorines, E. M. Martí-Ballesteros, M. D. Sánchez-Manzano, D. Carnevali-Ruiz, M. García-Coca, R. Barrena-Puertas, R. García de Viedma, J. M. Luque-Pinilla, G. Sotres-Fernandez, J. M. Fernández-Sousa, X. E. Luepke-Estefan, J. A. López-Martín and J. M. Jimeno
There is an urgent need for highly efficacious antiviral therapies in immunosuppressed hosts who develop coronavirus disease (COVID 19), with special concern for those affected by hematological malignancies.
Plitidepsin as a successful rescue treatment for prolonged viral SARS-CoV-2 replication in a patient with previous anti-CD20 monoclonal antibody-mediated B cell depletion and chronic lymphocytic leukemia | Journal of Hematology & Oncology | Full Text https://t.co/oYZjuPylKO